Reference
Takeyasu Y, et al. Impact of ALK inhibitors in patients with ALK-pearranged nonlung solid tumors. JCO Precision Oncology 5: 756-766, Jan 2021. Available from: URL: https://ascopubs.org/doi/pdf/10.1200/PO.20.00383
Rights and permissions
About this article
Cite this article
Alectinib/ceritinib/entrectinib. Reactions Weekly 1906, 29 (2022). https://doi.org/10.1007/s40278-022-14919-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-14919-8